Author: healthadmin

Bread has long been a cornerstone of the diet and has sustained society for generations. It is deeply woven into everyday life. But as obesity rates continue to rise, researchers are beginning to question whether this reliance on staple carbohydrates still makes sense in modern diets. Obesity increases the risk of many lifestyle diseases, making prevention a major public health priority. Traditionally, research has focused on high fat intake as the main factor in weight gain. This is why many animal studies rely on high-fat diets. However, although carbohydrates such as bread, rice, and noodles are consumed daily around the…

Read More

Wavelet Medical and Aegis Ventures have partnered to co-develop and scale the first non-invasive artificial intelligence-powered fetal electroencephalogram (EEG) monitoring platform. The companies aim to eliminate preventable brain injuries at birth, reduce unnecessary C-sections, and ultimately improve maternal and fetal outcomes. The companies say more than 35,000 infants in the United States suffer brain injuries at birth each year, and nearly one-third of births are delivered by cesarean section. Obstetric care has relied primarily on fetal heart rate monitoring (FHM) for decades. This tool does not directly measure neurological function and up to 85% of births are unknown. The Wavelet…

Read More

Researchers have discovered a way to make the immune system’s T cells even more effective at attacking cancer. By blocking a protein known as Ant2, they were able to change the way these cells produce and use energy, essentially rewiring their internal power supply. This change makes T cells more active and durable, increasing their ability to destroy tumors. This discovery points to a new treatment strategy that strengthens the body’s natural defenses and provides a more precise approach to cancer treatment. New research suggests a path to next-generation cancer treatments by training the immune system to respond more efficiently…

Read More

As artificial intelligence continues to rewrite the rules in countless industries, pharmaceutical companies are increasingly joining in, with AI partnerships ranging from narrow projects to company-wide efforts. Novo Nordisk falls into the latter category. On Tuesday morning, the company announced a partnership with OpenAI, ChatGPT’s parent company, to integrate AI “globally from drug discovery to commercial operations.” In an April 14 release, Novo said the company aims to “bring new and better treatment options to patients faster” through the teamup. Specifically, this includes leveraging AI to analyze complex data sets, identify promising new drug candidates, and shorten overall research and…

Read More

A small study comparing people with alcohol use disorder to healthy participants found that a single dose of a ketone ester supplement significantly reduced alcohol craving in participants with alcohol use disorder and shifted brain energy use from glucose to ketone bodies. The paper is Psychiatric research: neuroimaging. Ketone esters are synthetic compounds designed to increase the levels of ketone bodies in the blood without the need for fasting or a strict ketogenic diet. Ketones are alternative energy molecules naturally produced by the liver when carbohydrate intake is low, especially on an empty stomach or during prolonged exercise. The rationale…

Read More

The federal government will begin providing funding to states and health care providers this fall as part of a $50 billion rural health care transformation program. However, many organizations face challenges in deploying digital health infrastructure quickly enough to launch programs by the second half of this year. WebMD Ignite has launched a new program that provides an “ready-to-use” platform to help states, health systems, and local networks launch patient engagement, prevention, and access programs in just a few weeks, without the need for major system replacements or major IT investments. The company’s Health Education and Access for Rural Transformation…

Read More

A new study from the University of Hawai’i at Mānoa is reshaping decades-old thinking about the disappearance of Hawaii’s native waterfowl. Researchers report that there is no scientific evidence that indigenous peoples drove these species to extinction. Published in a magazine ecospherethe study challenges this widely accepted theory and introduces a broader explanation for why the birds have declined. The research team found no signs of widespread overfishing. Rather, they point to a combination of factors, including climate change, invasive species, and land-use change. Many of these changes occurred before Polynesians arrived in Hawaii or after traditional indigenous land management…

Read More

If you flush a toilet in the United States, you’re probably familiar with that signature hissing sound as a jet of water fills the toilet bowl and sucks up the contents with a dramatic gulp. In Europe, on the other hand, the process is very different. Most have the option of a lighter or stronger flash, depending on your needs. And the water is not sucked in, it just pushes the waste down. In stark contrast, in Germany and the Netherlands, waste may be deposited on ceramic shelves directly above puddles. All of this bathroom conversation is more than just…

Read More

We are pleased to announce the launch of an expanded assay development and screening facility at our headquarters in Chapel-en-le-Frice. The new 500 square meter facility builds on the company’s current integrated drug discovery capabilities and enhances support for the company’s global pharmaceutical and biotech customers. Concept Life Sciences’ Assay Development and Screening Group provides tailored assay development and screening platforms for a wide range of therapeutic indications and modalities. This expansion will allow Drug Hunters to significantly reduce project schedules and costs, allowing programs to seamlessly progress throughout the drug discovery process. This development builds on the company’s recent…

Read More

Recent research published in JAMA Psychiatry This suggests that psychedelic therapy may not be significantly more effective than standard antidepressants in treating depression when compared under similar conditions. The findings provide evidence that the impressive results seen in early psychedelic trials may have been influenced by study design rather than the unique chemical properties of the drugs themselves. This study helps clarify expectations for new mental health treatments and highlights the importance of fair comparisons in medicine. Psychedelic therapy combines psychological support with the supervised use of mind-altering substances like psilocybin, the active ingredient in “magic” mushrooms. Patients typically undergo…

Read More